Segall Bryant & Hamill LLC grew its holdings in SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) by 1.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 325,136 shares of the company’s stock after purchasing an additional 5,772 shares during the quarter. Segall Bryant & Hamill LLC owned about 0.46% of SIGA Technologies worth $2,195,000 as of its most recent filing with the SEC.
Several other large investors also recently made changes to their positions in the business. Vanguard Group Inc. raised its position in SIGA Technologies by 1.9% in the 1st quarter. Vanguard Group Inc. now owns 2,283,612 shares of the company’s stock worth $19,548,000 after purchasing an additional 41,515 shares during the last quarter. AltraVue Capital LLC raised its position in shares of SIGA Technologies by 6.6% during the second quarter. AltraVue Capital LLC now owns 2,177,646 shares of the company’s stock worth $16,528,000 after acquiring an additional 134,450 shares during the last quarter. Tidal Investments LLC acquired a new position in shares of SIGA Technologies during the first quarter valued at $157,000. Harbor Capital Advisors Inc. bought a new position in SIGA Technologies in the third quarter valued at about $1,098,000. Finally, Allspring Global Investments Holdings LLC increased its position in SIGA Technologies by 172.1% in the third quarter. Allspring Global Investments Holdings LLC now owns 211,236 shares of the company’s stock worth $1,426,000 after purchasing an additional 133,597 shares during the period. Institutional investors own 55.40% of the company’s stock.
SIGA Technologies Trading Up 3.3 %
Shares of NASDAQ:SIGA opened at $6.48 on Friday. SIGA Technologies, Inc. has a 1-year low of $4.26 and a 1-year high of $12.83. The stock has a market capitalization of $462.70 million, a P/E ratio of 5.40 and a beta of 0.89. The business has a 50-day moving average price of $7.03 and a two-hundred day moving average price of $7.86.
SIGA Technologies Company Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Further Reading
- Five stocks we like better than SIGA Technologies
- How to Invest in the Best Canadian Stocks
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- How to Invest in Insurance Companies: A Guide
- MarketBeat Week in Review – 11/18 – 11/22
- What is the Hang Seng index?
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.